MX2017016896A - Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos. - Google Patents

Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.

Info

Publication number
MX2017016896A
MX2017016896A MX2017016896A MX2017016896A MX2017016896A MX 2017016896 A MX2017016896 A MX 2017016896A MX 2017016896 A MX2017016896 A MX 2017016896A MX 2017016896 A MX2017016896 A MX 2017016896A MX 2017016896 A MX2017016896 A MX 2017016896A
Authority
MX
Mexico
Prior art keywords
methods
making
canine influenza
influenza vaccines
inactivated canine
Prior art date
Application number
MX2017016896A
Other languages
English (en)
Inventor
Wei Chiang Yu-
Cureton David
Poulet Herve
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of MX2017016896A publication Critical patent/MX2017016896A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

Cepas de virus de la influenza canina. Vacunas y composiciones que las contienen. Reactivos y métodos para detectarlas. Métodos de vacunación en los que se las emplea. Métodos para producir estos reactivos y estas vacunas.
MX2017016896A 2015-06-26 2016-06-23 Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos. MX2017016896A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562185266P 2015-06-26 2015-06-26
US201662298285P 2016-02-22 2016-02-22
PCT/US2016/038944 WO2016210083A2 (en) 2015-06-26 2016-06-23 Inactivated canine influenza vaccines and methods of making and uses thereof

Publications (1)

Publication Number Publication Date
MX2017016896A true MX2017016896A (es) 2018-04-10

Family

ID=56682237

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017016896A MX2017016896A (es) 2015-06-26 2016-06-23 Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.

Country Status (11)

Country Link
US (1) US10617752B2 (es)
EP (1) EP3313440A2 (es)
KR (1) KR20180021816A (es)
CN (1) CN107949398A (es)
AU (2) AU2016282761B2 (es)
CA (1) CA2990633A1 (es)
HK (1) HK1254522A1 (es)
MX (1) MX2017016896A (es)
NZ (1) NZ739260A (es)
TW (1) TWI733680B (es)
WO (1) WO2016210083A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016083287A1 (en) 2014-11-24 2016-06-02 Intervet International B.V. Inactivated equine influenza virus vaccines
MX2017016896A (es) * 2015-06-26 2018-04-10 Merial Inc Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.
CN109180820B (zh) * 2018-09-19 2021-06-25 天康生物制药有限公司 马流感病毒h3n8亚型的融合蛋白及其制备方法、应用和疫苗
WO2020076064A1 (ko) 2018-10-09 2020-04-16 엘지전자 주식회사 Mpm 리스트를 사용하는 인트라 예측 기반 영상 코딩 방법 및 그 장치
CN110680912B (zh) * 2019-09-26 2021-08-17 中国农业大学 H3n2和h3n8亚型犬流感二价灭活苗及其制备方法与应用
CN113173976B (zh) * 2021-06-03 2022-07-12 北京市农林科学院 一种犬流感病毒h3亚型ha蛋白、其制备方法和应用
WO2023102398A2 (en) * 2021-11-30 2023-06-08 Sab, Llc Ungulate-derived polyclonal immunoglobulin specific for influenza virus and uses thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
WO1996034109A1 (en) 1995-04-25 1996-10-31 Vical Incorporated Single-vial formulations of dna/lipid complexes
ES2241042T3 (es) 1996-10-11 2005-10-16 The Regents Of The University Of California Conjugados de polinucleotido inmunoestimulador/ molecula inmunomoduladora.
BRPI0412855B8 (pt) 2003-07-24 2022-06-28 Merial Inc formulações de vacina
US7691368B2 (en) 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
US7959929B2 (en) * 2005-04-21 2011-06-14 University Of Florida Research Foundation, Inc. Materials and methods for respiratory disease control in canines
AU2013205112C1 (en) 2005-10-19 2015-12-03 Cornell Research Foundation, Inc. Influenza viruses able to infect canids, uses thereof
KR100850545B1 (ko) * 2007-10-30 2008-08-05 주식회사 에니멀제네틱스 신규한 개 인플루엔자 바이러스 및 이의 백신
KR101746880B1 (ko) 2009-09-10 2017-06-14 메리얼 인코포레이티드 사포닌-함유 면역보강제를 포함하는 신규 백신 제형
CN102220293B (zh) 2011-05-26 2012-12-19 中国农业科学院上海兽医研究所 犬流感重组病毒及其制备方法和应用
KR101511619B1 (ko) * 2013-04-30 2015-04-13 한국생명공학연구원 개 인플루엔자 바이러스 h3n2의 ha1 단백질을 항원으로 포함하는 개 인플루엔자 바이러스 h3n2에 특이적인 혈청 진단용 키트
MX2017016896A (es) * 2015-06-26 2018-04-10 Merial Inc Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.

Also Published As

Publication number Publication date
TWI733680B (zh) 2021-07-21
US20180250382A1 (en) 2018-09-06
AU2016282761B2 (en) 2019-07-04
AU2019204526A1 (en) 2019-07-18
CN107949398A (zh) 2018-04-20
AU2016282761A1 (en) 2018-02-15
US10617752B2 (en) 2020-04-14
TW201716083A (zh) 2017-05-16
CA2990633A1 (en) 2016-12-29
EP3313440A2 (en) 2018-05-02
NZ739260A (en) 2019-09-27
WO2016210083A3 (en) 2017-02-23
HK1254522A1 (zh) 2019-07-19
KR20180021816A (ko) 2018-03-05
WO2016210083A2 (en) 2016-12-29

Similar Documents

Publication Publication Date Title
MX2022006603A (es) Vacuna contra el virus de la influenza de amplio espectro.
MX2017016896A (es) Vacunas inactivadas contra la influenza canina, metodos para elaborarlas y sus usos.
PH12018500856A1 (en) Respiratory syncytial virus vaccine
PH12018500855A1 (en) Herpes simplex virus vaccine
WO2017070626A3 (en) Respiratory virus vaccines
MX2021010060A (es) Produccion de virus en huevos aviares.
BR112016024644A2 (pt) vacinas de ácido nucleico
AU2015296298A8 (en) Flagellin-based agents and uses including effective vaccination
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
WO2015052543A3 (en) Malaria vaccination
PH12019501569A1 (en) Universal influenza vaccine compositions
MX2016016746A (es) Composiciones de vacuna con adyuvante dual, preparacion y usos.
MX2017014414A (es) Metodo para la produccion de circovirus porcino y vacunas pcv2.
MX2019005102A (es) Poxvirus quimericos sinteticos.
EP3939604A3 (en) Influenza hemagglutinin protein vaccines
MX2018014955A (es) Vacunas atenuadas vivas del virus de la influenza equina.
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
MX2019007924A (es) Vacunas contra la influenza.
MX2015015428A (es) Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
PH12019501173A1 (en) Attenuated swine influenza vaccines and methods of making and use thereof
EA201892385A1 (ru) Модификация сконструированных полипептидов гемагглютинина вируса гриппа
PH12017502378A1 (en) Inactivated canine influenza vaccines and methods of making and uses thereof
WO2015196180A3 (en) Influenza vaccines and methods of use thereof
PL406631A1 (pl) Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie
WO2017011620A3 (en) Methods and compositions related to increasing the fidelity of influenza a virus for vaccine development